VistaGen Therapeutics Inc banner
V

VistaGen Therapeutics Inc
NASDAQ:VTGN

Watchlist Manager
VistaGen Therapeutics Inc
NASDAQ:VTGN
Watchlist
Price: 0.5508 USD -1.64%
Market Cap: $21.8m

Balance Sheet

Balance Sheet Decomposition
VistaGen Therapeutics Inc

Balance Sheet
VistaGen Therapeutics Inc

Rotate your device to view
Balance Sheet
Currency: USD
Dec-2006 Dec-2007 Dec-2008 Dec-2009 Dec-2010 Mar-2012 Mar-2013 Mar-2014 Mar-2015 Mar-2016 Mar-2017 Mar-2018 Mar-2019 Mar-2020 Mar-2021 Mar-2022 Mar-2023 Mar-2024 Mar-2025
Assets
Cash & Cash Equivalents
0
0
0
0
0
0
1
0
0
0
3
10
13
1
103
68
17
119
67
Cash
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
Cash Equivalents
0
0
0
0
0
0
1
0
0
0
3
10
13
1
103
68
17
119
67
Short-Term Investments
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
13
Total Receivables
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
Accounts Receivables
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
Other Receivables
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
Other Current Assets
0
0
0
0
0
0
0
0
0
0
1
1
0
0
1
3
1
2
2
Total Current Assets
0
0
0
0
0
0
1
0
0
1
3
11
14
2
104
71
18
121
82
PP&E Net
0
0
0
0
0
0
0
0
0
0
0
0
0
4
4
3
3
2
2
PP&E Gross
0
0
0
0
0
0
0
0
0
0
0
0
0
4
4
3
3
2
2
Accumulated Depreciation
0
0
0
0
0
1
1
1
0
0
0
0
1
1
1
1
1
1
1
Other Long-Term Assets
0
0
0
0
0
0
0
0
0
0
0
0
0
0
1
1
1
1
0
Total Assets
0
N/A
0
N/A
0
N/A
0
N/A
0
N/A
0
N/A
1
+200%
0
-67%
0
N/A
1
+233%
4
+270%
11
+205%
14
+24%
6
-59%
108
+1 767%
75
-31%
21
-72%
124
+486%
84
-32%
Liabilities
Accounts Payable
0
0
0
0
0
2
1
2
2
1
1
1
1
2
1
3
3
2
1
Accrued Liabilities
0
0
0
0
0
1
0
1
1
1
0
0
2
1
2
2
1
3
9
Short-Term Debt
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
Current Portion of Long-Term Debt
0
0
0
0
0
1
1
2
14
0
0
0
0
0
0
0
0
0
0
Other Current Liabilities
0
0
0
0
0
0
0
0
0
0
0
0
0
0
1
1
1
1
3
Total Current Liabilities
0
0
0
0
0
3
2
5
17
2
1
2
3
3
4
6
5
5
13
Long-Term Debt
0
0
0
0
0
3
5
5
0
0
0
0
0
0
0
0
0
0
0
Other Liabilities
0
0
0
0
0
0
6
3
3
2
2
3
4
9
12
4
4
4
1
Total Liabilities
0
N/A
0
N/A
0
N/A
0
N/A
0
N/A
6
N/A
13
+123%
13
-2%
21
+59%
4
-81%
3
-23%
4
+42%
7
+57%
12
+67%
16
+42%
10
-39%
9
-9%
9
+4%
14
+49%
Equity
Common Stock
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
Retained Earnings
0
0
0
0
0
55
68
71
85
132
142
157
181
202
220
268
327
356
408
Additional Paid In Capital
0
0
0
0
0
53
59
62
68
133
147
167
192
200
316
336
343
474
482
Treasury Stock
0
0
0
0
0
3
4
4
4
4
4
4
4
4
4
4
4
4
4
Other Equity
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
Total Equity
0
N/A
0
N/A
0
N/A
0
N/A
0
N/A
6
N/A
13
-121%
13
-2%
21
-60%
3
+85%
1
N/A
7
+1 050%
7
+3%
6
N/A
92
N/A
65
-30%
12
-81%
114
+845%
70
-38%
Total Liabilities & Equity
0
N/A
0
N/A
0
N/A
0
N/A
0
N/A
0
N/A
1
+200%
0
-67%
0
N/A
1
+233%
4
+270%
11
+205%
14
+24%
6
-59%
108
+1 767%
75
-31%
21
-72%
124
+486%
84
-32%
Shares Outstanding
Common Shares Outstanding
0
0
0
0
0
0
0
0
0
0
0
1
1
2
6
7
7
27
29
Preferred Shares Outstanding
0
0
0
0
0
0
1
1
1
7
4
4
4
4
4
0
0
0
0